Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment
Morie A. Gertz
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
60
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Immunoglobulin Light-chain Amyloidosis
100%
Immunoglobulin Light Chains
76%
Dexamethasone
68%
Amyloid
52%
Lenalidomide
49%
Bortezomib
45%
Melphalan
45%
Troponin T
45%
Brain Natriuretic Peptide
41%
Amyloid Plaques
40%
Cyclophosphamide
34%
Biopsy
33%
Restrictive Cardiomyopathy
27%
Stem Cells
27%
Birefringence
27%
Congo Red
24%
Transplants
23%
Thalidomide
23%
Nephrotic Syndrome
20%
Subcutaneous Fat
20%
Survival
20%
Delayed Diagnosis
20%
Liver Failure
20%
Peripheral Nervous System Diseases
19%
Prednisone
18%
Combination Drug Therapy
18%
Plasma Cells
18%
Multiple Myeloma
18%
Serum
16%
Creatinine
14%
Bone Marrow
13%
Therapeutics
12%